Last reviewed · How we verify
Use of Mitomycin-C in trabeculectomy
Use of Mitomycin-C in trabeculectomy is a Small molecule drug developed by Aeon Astron Europe B.V.. It is currently in Phase 1 development.
At a glance
| Generic name | Use of Mitomycin-C in trabeculectomy |
|---|---|
| Sponsor | Aeon Astron Europe B.V. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy (PHASE4)
- Evaluation of Retina in Patients With Glaucoma Using Topical Prostaglandins Undergoing Trabeculectomy Surgery (NA)
- Comparison of Ex-PRESSTM Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle Glaucoma (NA)
- Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy (PHASE1)
- Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery (PHASE4)
- Use of Ranibizumab With Mitomycin C During Trabeculectomy (PHASE1, PHASE2)
- Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma (PHASE2, PHASE3)
- Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Use of Mitomycin-C in trabeculectomy CI brief — competitive landscape report
- Use of Mitomycin-C in trabeculectomy updates RSS · CI watch RSS
- Aeon Astron Europe B.V. portfolio CI
Frequently asked questions about Use of Mitomycin-C in trabeculectomy
What is Use of Mitomycin-C in trabeculectomy?
Use of Mitomycin-C in trabeculectomy is a Small molecule drug developed by Aeon Astron Europe B.V..
Who makes Use of Mitomycin-C in trabeculectomy?
Use of Mitomycin-C in trabeculectomy is developed by Aeon Astron Europe B.V. (see full Aeon Astron Europe B.V. pipeline at /company/aeon-astron-europe-b-v).
What development phase is Use of Mitomycin-C in trabeculectomy in?
Use of Mitomycin-C in trabeculectomy is in Phase 1.